Vivotek Inc. Logo

Vivotek Inc.

3454.TW

(2.2)
Stock Price

122,50 TWD

10.44% ROA

13.98% ROE

21.06x PER

Market Cap.

13.634.460.000,00 TWD

16.63% DER

3.49% Yield

5.34% NPM

Vivotek Inc. Stock Analysis

Vivotek Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Vivotek Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (18.55%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 DER

The stock has a low debt to equity ratio (17%), which means it has a small amount of debt compared to the ownership it holds

4 Dividend

The company's consistent dividend payouts over the past five years exemplify its strong commitment to providing shareholders with reliable returns, making it an attractive investment option.

5 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (3.747), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

6 PBV

The stock's high Price-to-Book Value (P/BV) ratio (3.64x) suggests it's overvalued, potentially making it an expensive investment.

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

10 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

Vivotek Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Vivotek Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Vivotek Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Vivotek Inc. Revenue
Year Revenue Growth
2009 1.116.839.000
2010 1.758.626.000 36.49%
2011 2.873.867.000 38.81%
2012 3.469.878.000 17.18%
2013 4.112.916.000 15.63%
2014 3.682.127.000 -11.7%
2015 4.138.752.000 11.03%
2016 4.800.228.000 13.78%
2017 5.876.591.000 18.32%
2018 5.235.966.000 -12.24%
2019 6.573.617.000 20.35%
2020 5.544.433.000 -18.56%
2021 5.451.605.000 -1.7%
2022 9.948.137.000 45.2%
2023 9.262.708.000 -7.4%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Vivotek Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2009 203.793.000
2010 241.800.000 15.72%
2011 303.190.000 20.25%
2012 344.100.000 11.89%
2013 403.706.000 14.76%
2014 482.320.000 16.3%
2015 555.568.000 13.18%
2016 640.716.000 13.29%
2017 680.883.000 5.9%
2018 647.683.000 -5.13%
2019 735.767.000 11.97%
2020 730.057.000 -0.78%
2021 645.622.000 -13.08%
2022 721.538.000 10.52%
2023 737.768.000 2.2%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Vivotek Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2009 85.533.000
2010 136.177.000 37.19%
2011 208.822.000 34.79%
2012 162.792.000 -28.28%
2013 167.365.000 2.73%
2014 192.031.000 12.84%
2015 207.182.000 7.31%
2016 203.058.000 -2.03%
2017 218.861.000 7.22%
2018 190.539.000 -14.86%
2019 209.867.000 9.21%
2020 223.653.000 6.16%
2021 216.187.000 -3.45%
2022 240.329.000 10.05%
2023 284.152.000 15.42%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Vivotek Inc. EBITDA
Year EBITDA Growth
2009 152.208.000
2010 297.501.000 48.84%
2011 588.208.000 49.42%
2012 777.829.000 24.38%
2013 970.552.000 19.86%
2014 542.431.000 -78.93%
2015 672.124.000 19.3%
2016 752.366.000 10.67%
2017 647.535.000 -16.19%
2018 452.074.000 -43.24%
2019 543.243.000 16.78%
2020 512.460.000 -6.01%
2021 408.051.000 -25.59%
2022 1.022.904.000 60.11%
2023 962.816.000 -6.24%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Vivotek Inc. Gross Profit
Year Gross Profit Growth
2009 446.936.000
2010 766.785.000 41.71%
2011 1.248.284.000 38.57%
2012 1.605.390.000 22.24%
2013 1.852.379.000 13.33%
2014 1.573.841.000 -17.7%
2015 1.763.789.000 10.77%
2016 2.031.231.000 13.17%
2017 2.049.964.000 0.91%
2018 1.800.304.000 -13.87%
2019 2.039.448.000 11.73%
2020 1.868.129.000 -9.17%
2021 1.611.703.000 -15.91%
2022 2.587.770.000 37.72%
2023 2.602.972.000 0.58%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Vivotek Inc. Net Profit
Year Net Profit Growth
2009 81.237.000
2010 195.992.000 58.55%
2011 455.247.000 56.95%
2012 575.726.000 20.93%
2013 724.402.000 20.52%
2014 367.873.000 -96.92%
2015 474.420.000 22.46%
2016 520.836.000 8.91%
2017 430.456.000 -21%
2018 329.578.000 -30.61%
2019 274.905.000 -19.89%
2020 250.823.000 -9.6%
2021 188.138.000 -33.32%
2022 702.195.000 73.21%
2023 582.764.000 -20.49%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Vivotek Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2009 1
2010 3 50%
2011 5 60%
2012 7 16.67%
2013 9 25%
2014 4 -100%
2015 6 20%
2016 6 16.67%
2017 5 -20%
2018 4 -66.67%
2019 3 0%
2020 3 -50%
2021 2 0%
2022 8 75%
2023 7 -33.33%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Vivotek Inc. Free Cashflow
Year Free Cashflow Growth
2009 -7.231.000
2010 188.500.000 103.84%
2011 179.670.000 -4.91%
2012 394.832.000 54.49%
2013 765.387.000 48.41%
2014 272.400.000 -180.98%
2015 132.642.000 -105.36%
2016 615.923.000 78.46%
2017 2.881.000 -21278.79%
2018 -322.834.000 100.89%
2019 632.996.000 151%
2020 428.146.000 -47.85%
2021 25.082.000 -1606.99%
2022 368.703.000 93.2%
2023 711.807.000 48.2%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Vivotek Inc. Operating Cashflow
Year Operating Cashflow Growth
2009 173.777.000
2010 264.650.000 34.34%
2011 262.677.000 -0.75%
2012 590.179.000 55.49%
2013 892.494.000 33.87%
2014 531.037.000 -68.07%
2015 323.514.000 -64.15%
2016 779.240.000 58.48%
2017 426.903.000 -82.53%
2018 73.673.000 -479.46%
2019 808.770.000 90.89%
2020 501.406.000 -61.3%
2021 121.766.000 -311.78%
2022 468.397.000 74%
2023 734.522.000 36.23%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Vivotek Inc. Capital Expenditure
Year Capital Expenditure Growth
2009 181.008.000
2010 76.150.000 -137.7%
2011 83.007.000 8.26%
2012 195.347.000 57.51%
2013 127.107.000 -53.69%
2014 258.637.000 50.86%
2015 190.872.000 -35.5%
2016 163.317.000 -16.87%
2017 424.022.000 61.48%
2018 396.507.000 -6.94%
2019 175.774.000 -125.58%
2020 73.260.000 -139.93%
2021 96.684.000 24.23%
2022 99.694.000 3.02%
2023 22.715.000 -338.89%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Vivotek Inc. Equity
Year Equity Growth
2009 978.354.000
2010 1.223.801.000 20.06%
2011 1.634.707.000 25.14%
2012 1.923.416.000 15.01%
2013 2.233.960.000 13.9%
2014 2.357.650.000 5.25%
2015 2.563.785.000 8.04%
2016 2.758.624.000 7.06%
2017 2.808.219.000 1.77%
2018 2.851.069.000 1.5%
2019 2.913.563.000 2.14%
2020 2.899.548.000 -0.48%
2021 2.953.718.000 1.83%
2022 3.597.664.000 17.9%
2023 3.543.720.000 -1.52%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Vivotek Inc. Assets
Year Assets Growth
2009 1.419.837.000
2010 1.654.945.000 14.21%
2011 2.231.125.000 25.82%
2012 2.723.740.000 18.09%
2013 3.183.536.000 14.44%
2014 3.250.040.000 2.05%
2015 3.643.927.000 10.81%
2016 3.945.748.000 7.65%
2017 4.328.118.000 8.83%
2018 4.457.566.000 2.9%
2019 4.627.860.000 3.68%
2020 4.747.190.000 2.51%
2021 5.345.177.000 11.19%
2022 7.075.445.000 24.45%
2023 6.242.797.000 -13.34%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Vivotek Inc. Liabilities
Year Liabilities Growth
2009 412.080.000
2010 409.654.000 -0.59%
2011 593.404.000 30.97%
2012 809.100.000 26.66%
2013 907.342.000 10.83%
2014 765.757.000 -18.49%
2015 952.233.000 19.58%
2016 1.060.025.000 10.17%
2017 1.419.648.000 25.33%
2018 1.606.497.000 11.63%
2019 1.714.297.000 6.29%
2020 1.847.642.000 7.22%
2021 2.391.459.000 22.74%
2022 3.477.781.000 31.24%
2023 2.699.077.000 -28.85%

Vivotek Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
123.37
Net Income per Share
7.48
Price to Earning Ratio
21.06x
Price To Sales Ratio
1.27x
POCF Ratio
8.28
PFCF Ratio
8.75
Price to Book Ratio
3.92
EV to Sales
1.15
EV Over EBITDA
12.76
EV to Operating CashFlow
7.45
EV to FreeCashFlow
7.89
Earnings Yield
0.05
FreeCashFlow Yield
0.11
Market Cap
13,63 Bil.
Enterprise Value
12,29 Bil.
Graham Number
82.18
Graham NetNet
11.25

Income Statement Metrics

Net Income per Share
7.48
Income Quality
2.17
ROE
0.19
Return On Assets
0.08
Return On Capital Employed
0.15
Net Income per EBT
0.85
EBT Per Ebit
1
Ebit per Revenue
0.06
Effective Tax Rate
0.11

Margins

Sales, General, & Administrative to Revenue
0.03
Research & Developement to Revenue
0.07
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.26
Operating Profit Margin
0.06
Pretax Profit Margin
0.06
Net Profit Margin
0.05

Dividends

Dividend Yield
0.03
Dividend Yield %
3.49
Payout Ratio
0
Dividend Per Share
5.5

Operating Metrics

Operating Cashflow per Share
19.02
Free CashFlow per Share
17.96
Capex to Operating CashFlow
-0.06
Capex to Revenue
-0.01
Capex to Depreciation
-0.52
Return on Invested Capital
0.17
Return on Tangible Assets
0.1
Days Sales Outstanding
42.95
Days Payables Outstanding
54.27
Days of Inventory on Hand
74.28
Receivables Turnover
8.5
Payables Turnover
6.73
Inventory Turnover
4.91
Capex per Share
-1.06

Balance Sheet

Cash per Share
21,96
Book Value per Share
40,13
Tangible Book Value per Share
40.86
Shareholders Equity per Share
40.13
Interest Debt per Share
6.8
Debt to Equity
0.17
Debt to Assets
0.09
Net Debt to EBITDA
-1.39
Current Ratio
1.95
Tangible Asset Value
3,51 Bil.
Net Current Asset Value
2,14 Bil.
Invested Capital
0.17
Working Capital
2,35 Bil.
Intangibles to Total Assets
0
Average Receivables
1,30 Bil.
Average Payables
1,24 Bil.
Average Inventory
1886071500
Debt to Market Cap
0.04

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Vivotek Inc. Dividends
Year Dividends Growth
2008 2
2009 1 0%
2010 1 0%
2011 2 100%
2012 4 66.67%
2013 5 25%
2014 6 20%
2015 4 -66.67%
2016 4 25%
2017 4 0%
2018 4 -33.33%
2019 3 -50%
2020 3 0%
2021 2 0%
2022 1 -100%
2023 6 80%

Vivotek Inc. Profile

About Vivotek Inc.

Vivotek Inc., together with its subsidiaries, provides security surveillance solutions. It operates through four segments: OBM, ODM, Vivotek USA, and Vatics. The company offers network cameras, video servers and receivers, network video recorders, AI boxes, video management software, VMS stations, application software, and power over Ethernet switches, as well as offers cloud-based monitoring management system. It also provides accessories comprising mounting kits, enclosures, covers, lens, power supply and box products, cables, joysticks, cabinets, cabinet accessories, storage products, water tanks, illuminators, and connectors. In addition, the company engages in the sale of lighting equipment; investment and commercial lease of real estate; and investment in network communications industry, as well as designs and sells multimedia ICs. It operates in the United states, Taiwan, Canada, Japan, France, Australia, Mexico, India, and internationally. The company sells its products and services through distributors. Vivotek Inc. was incorporated in 2000 and is headquartered in New Taipei City, Taiwan.

CEO
Chi Liao Chen
Employee
1.273
Address
No. 192, Lien-Cheng Road
New Taipei City, 23553

Vivotek Inc. Executives & BODs

Vivotek Inc. Executives & BODs
# Name Age
1 Mr. Gordon Chen
Senior Vice President of ODM Business Division
70
2 Mr. William Ku
Senior Vice President of Brand Business Division
70
3 Ms. Mei-Yu Li
Head of Accounting, Finance & Corporate Governance and Company Secretary
70
4 Ren Zhi Wu
Deputy GM & Chief Technology Officer
70
5 Ms. Li-Ting Huang
Chief Audit
70
6 Chi Liao Chen
President
70
7 Mr. Fan-Xun Zhen
Vice President of Global Business Division
70

Vivotek Inc. Competitors

GeoVision Inc. Logo
GeoVision Inc.

3356.TW

(2.2)
Sercomm Corporation Logo
Sercomm Corporation

5388.TW

(2.8)
Global Unichip Corp. Logo
Global Unichip Corp.

3443.TW

(3.5)